Beta Phenyl Ethyl Amine (BPEA) (CAS No. 64-04-0) from Galaxy Laboratories is a premium pharmaceutical API intermediate manufactured for its excellent chemical stability and solubility. It has been produced under stringent quality and regulatory conditions, producing a reliable compound with 99% purity.
Note: Product Fulfillment Provided by the Producer
Note: The producer provides fulfillment and controls personal data. ChemPoint mediates to share data with the producer.
Beta Phenyl Ethyl Amine [ 2-Phenyl Ethyl Amine] [BPEA] is an advanced API intermediate and chemical ingredient formulated for high-quality pharmaceutical materials treating diabetes, helminthiasis, and more. BPEA also exhibits sympathomimetic properties to influence the central nervous system and treat a variety of conditions.
Galaxy Laboratories manufactures Beta Phenyl Ethyl Amine [ 2-Phenyl Ethyl Amine] in an ISO and cGMP-certified facility with strict quality control and safety standards.
Appearance: Colorless to pale yellow color liquid
Molecular weight: 121.18
Density @ 25°C: 0.955 to 0.970 gm/ml
Moisture content by KF: Not more than 0.50%
Refractive index at 25°C: 1.530 to 1.534
Purity by G: Not less than 99.0%
Individual impurity: Not more than 0.50%
Total impurities: Not more than 1.00%
CAS No. 64-04-0
Primary Chemistry:
Beta Phenyl Ethyl Amine [ 2-Phenyl Ethyl Amine] [BPEA]
Diabetes
Helminthiasis
Sympathomimetic (Uncontrollable urination)
BPEA is a key pharmaceutical API intermediate for:
-Praziquantel anthelmintics
-Mirabegron sympathomimetic
-Glibenclamide antidiabetic
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - Europe, Middle East, Africa
View Support Articles
Talk to an Expert
Ask a Question
